Clinical Trial Detail

NCT ID NCT02754297
Title Personalized PRRT of Neuroendocrine Tumors (P-PRRT)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors CHU de Quebec-Universite Laval
Indications

neuroendocrine tumor

Therapies

lutetium Lu 177 dotatate

Age Groups: adult senior

No variant requirements are available.